Home / BusinessBusinessCNBCBusinessCNBC·Aug 6, 2026·1 min readAstraZeneca may buck a decade of pharma strategy to buy U.S. scaleReports of preliminary talks between AstraZeneca and Bristol Myers Squibb moved shares and reignited debate over Big Pharma consolidation.View original source — CNBC ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessMarketWatchBusinessAug 6, 2026 · 1 minHedge funds forced out of tech stocks may leave the market at the mercy of retail tradersMarketWatchBusinessCNBCBusinessAug 6, 2026 · 1 minPeloton delivers first annual net profit ever in 'landmark' financial yearCNBCBusinessCNBCBusinessAug 6, 2026 · 1 minWorld's biggest spirits maker pops 6% on $1 billion cost-cutting planCNBCBusinessBloombergBusinessAug 6, 2026 · 1 minIndonesia’s Plan to Overhaul Commodity Exports Is Still in FluxBloomberg
BusinessMarketWatchBusinessAug 6, 2026 · 1 minHedge funds forced out of tech stocks may leave the market at the mercy of retail tradersMarketWatch
BusinessCNBCBusinessAug 6, 2026 · 1 minPeloton delivers first annual net profit ever in 'landmark' financial yearCNBC
BusinessCNBCBusinessAug 6, 2026 · 1 minWorld's biggest spirits maker pops 6% on $1 billion cost-cutting planCNBC
BusinessBloombergBusinessAug 6, 2026 · 1 minIndonesia’s Plan to Overhaul Commodity Exports Is Still in FluxBloomberg